Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 8 (4), 89-95

Issues in Diagnostic Testing and Monitoring in HIV/viral Hepatitis Co-Infection

Affiliations
  • PMID: 14671506
Review

Issues in Diagnostic Testing and Monitoring in HIV/viral Hepatitis Co-Infection

Samir Dervisevic et al. J HIV Ther.

Abstract

Co-infection with HIV and hepatitis B (HBV)/ hepatitis C virus (HCV) occurs commonly due to similar routes of transmission. Both hepatotropic viruses can cause a severe clinical picture in HIV-infected individuals with rapid progression of liver disease, cirrhosis and increased mortality. Fortunately, treatment options of HBV and HCV are becoming well established and may have a clinical impact in slowing disease progression. This, coupled with the fact that highly active antiretroviral therapy (HAART) has increased the life expectancy of HIV-infected patients stresses the importance of management of concurrent illnesses such as HBV and HCV infection, taking into consideration pharmacokinetic interaction with components of HAART regimens.

Similar articles

See all similar articles

Cited by 1 article

MeSH terms

Feedback